Basit öğe kaydını göster

dc.contributor.authorYÜCESAN, EMRAH
dc.contributor.authorSengenc, Esma
dc.contributor.authorYesil, Gozde
dc.contributor.authorAslanger, Ayca Dilruba
dc.contributor.authorGÖNCÜ, BEYZA SERVET
dc.contributor.authorDuzenli, Omer Faruk
dc.date.accessioned2022-02-18T10:36:40Z
dc.date.available2022-02-18T10:36:40Z
dc.identifier.citationAslanger A. D. , GÖNCÜ B. S. , Duzenli O. F. , YÜCESAN E., Sengenc E., Yesil G., "Biallelic loss of TRAPPC9 function links vesicle trafficking pathway to autosomal recessive intellectual disability", JOURNAL OF HUMAN GENETICS, 2022
dc.identifier.issn1434-5161
dc.identifier.othervv_1032021
dc.identifier.otherav_ac2a62d5-3caf-432b-939b-be5fd8f68da2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179562
dc.identifier.urihttps://doi.org/10.1038/s10038-021-01007-8
dc.description.abstractBackground The trafficking protein particle (TRAPP) complex subunit 9 (C9) protein is a member of TRAPP-II complexes and regulates vesicle trafficking. Biallelic mutations in the TRAPPC9 gene are responsible for intellectual disability with expanded developmental delay, epilepsy, microcephaly, and brain atrophy. TRAPPC9-related disease list is still expanding, however, the functional effects of only a limited fraction of these have been studied. Methods In a patient with a pathological variant in TRAPPC9, clinical examination and cranial imaging findings were evaluated. Whole-exome sequencing, followed by Sanger sequencing was performed to detect and verify the variant. To confirm the functional effect of the mutation; variant mRNA and protein expression levels were evaluated by qRT-PCR and Western blotting. Immunostaining for TRAPPC9 and lipid droplet accumulation were examined. Results We have identified a novel homozygous c.696C>G (p.Phe232Leu) pathogenic variant in TRAPPC9 (NM_031466.6) gene as a cause of severe developmental delay. Functional characterization of the TRAPPC9 variant resulted in decreased mRNA and protein expression. The intracellular findings showed that TRAPPC9 protein build-up around the nucleus in mutant type while there was no specific accumulation in the control cell line. This disrupted protein pattern affected the amount of neutral lipid-carrying vesicles and their homogenous distribution at a decreasing level. Conclusion Biallelic variants in the TRAPPC9 gene have been reported as the underlying cause of intellectual disability. This study provides functional evidence of the novel variant in TRAPPC9 We demonstrated that the loss of function variant exclusively targeting TRAPPC9 may explicate the neurological findings through vesicle trafficking.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Genetik
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectGenetics
dc.subjectMolecular Biology
dc.subjectGenetics (clinical)
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectGENETİK VE HAYAT
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleBiallelic loss of TRAPPC9 function links vesicle trafficking pathway to autosomal recessive intellectual disability
dc.typeMakale
dc.relation.journalJOURNAL OF HUMAN GENETICS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID3060672


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster